DexCom Net Income decreased by 25.4% to $199.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 89.3%, from $105.40M to $199.50M. Over 4 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 39.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.40M | $87.30M | $0.00 | $97.30M | $50.90M | $101.20M | $91.80M | $48.60M | $115.90M | $120.70M | $256.30M | $146.40M | $143.50M | $134.60M | $151.70M | $105.40M | $179.80M | $283.80M | $267.30M | $199.50M |
| QoQ Change | — | +11.4% | -100.0% | — | -47.7% | +98.8% | -9.3% | -47.1% | +138.5% | +4.1% | +112.3% | -42.9% | -2.0% | -6.2% | +12.7% | -30.5% | +70.6% | +57.8% | -5.8% | -25.4% |
| YoY Change | — | — | — | — | -35.1% | +15.9% | — | -50.1% | +127.7% | +19.3% | +179.2% | +201.2% | +23.8% | +11.5% | -40.8% | -28.0% | +25.3% | +110.8% | +76.2% | +89.3% |